Security key
092667104
Strata Critical Medical, Inc. - Common Stock (SRTA)
CUSIP: 092667104
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 55,803,500
- Total 13F value
- $233,248,404
- Share change
- +3,695,366
- Put/Call ratio
- 16%
- SEC-reported price per share
- $4.18
- Number of holders
- 125
- Value change
- +$14,870,345
- Number of buys
- 64
- Number of sells
- 52
- Shares outstanding
- 86,419,462
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
125
Top holders
10
SRTA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Strata Critical Medical, Inc. SEC filings
Strata Critical Medical, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 092667104
Recent filing periods:
Ownership snapshot
Top reported holders of SRTA - Strata Critical Medical, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Third Point LLC
Disclosed value leader
ARK Investment Management...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
3/4/5
Lead comparable stake: 5.8%
13D/G row: Third Point LLC
Showing 1-6 of 15 holder rows.
Quick read
Third Point LLC leads the comparable SEC ownership view at 5.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Third Point LLC's linked filing trail.
Comparable ownership
Top 5
Third Point LLC
5.8%
BlackRock, Inc.
5.1%
Louis R. Verdetto
1.5%
Eric L. Affeldt
0.67%
John Borthwick
0.24%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Third Point LLC |
13D/G
13F
Company
|
5.8%
|
$25,300,000
5,000,000 shares
|
$0 | 30 Sep 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.1%
from 13D/G
|
$21,614,302
4,493,667 shares
mixed-class rows
|
— | 31 Dec 2025 |
| Louis R. Verdetto |
3/4/5
CEO Keystone Perfusion Service
|
1.5%
|
$6,456,727
1,266,025 shares
|
— | 02 Dec 2025 |
| Eric L. Affeldt |
3/4/5
Director
|
0.67%
|
$2,353,916
581,214 shares
|
— | 01 Aug 2025 |
| John Borthwick |
3/4/5
Director
|
0.24%
|
$826,106
203,977 shares
|
— | 01 Aug 2025 |
| Kenneth B. Lerer |
3/4/5
Director
|
0.23%
|
$797,278
196,859 shares
|
— | 01 Aug 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
125
Shares
55,803,500
Rows available
125
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
125
Q1 2026 holders
125
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend